These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 6703503)
1. Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice. Kuze F Am Rev Respir Dis; 1984 Mar; 129(3):453-9. PubMed ID: 6703503 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs. Kuze F; Kurasawa T; Bando K; Lee Y; Maekawa N Rev Infect Dis; 1981; 3(5):885-97. PubMed ID: 7339820 [TBL] [Abstract][Full Text] [Related]
5. Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice. Saito H; Sato K Tubercle; 1989 Sep; 70(3):201-5. PubMed ID: 2559522 [TBL] [Abstract][Full Text] [Related]
6. Control of Mycobacterium fortuitum and Mycobacterium intracellulare infections with respect to distinct granuloma formations in livers of BALB/c mice. Silva TR; Petersen AL; Santos Tde A; Almeida TF; Freitas LA; Veras PS Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):642-8. PubMed ID: 20835610 [TBL] [Abstract][Full Text] [Related]
7. Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice. de Steenwinkel JE; van Vianen W; Ten Kate MT; Verbrugh HA; van Agtmael MA; Schiffelers RM; Bakker-Woudenberg IA J Antimicrob Chemother; 2007 Nov; 60(5):1064-73. PubMed ID: 17846106 [TBL] [Abstract][Full Text] [Related]
8. A resected case of Mycobacterium szulgai pulmonary disease. Tsuyuguchi K; Amitani R; Matsumoto H; Tanaka E; Suzuki K; Yanagihara K; Mizuno H; Hitomi S; Kuze F Int J Tuberc Lung Dis; 1998 Mar; 2(3):258-60. PubMed ID: 9526201 [TBL] [Abstract][Full Text] [Related]
9. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)]. Kuze F; Lee Y; Maekawa N; Suzuki Y Kekkaku; 1979 Sep; 54(9):453-60. PubMed ID: 502152 [No Abstract] [Full Text] [Related]
10. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection. Murray MP; Laurenson IF; Hill AT Clin Infect Dis; 2008 Jul; 47(2):222-4. PubMed ID: 18532890 [TBL] [Abstract][Full Text] [Related]
11. [Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex]. Tsukamura M Kekkaku; 1991 May; 66(5):375-80. PubMed ID: 1875580 [TBL] [Abstract][Full Text] [Related]
12. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial]. Tanaka E Kekkaku; 1996 Sep; 71(9):547-9. PubMed ID: 8999140 [No Abstract] [Full Text] [Related]
13. [A study on drug regimens against Mycobacterium avium-intracellulare infection--(1) Delayed therapy of murine infection]. Sakurai N; Kuze F Kekkaku; 1986 Jun; 61(6):333-9. PubMed ID: 3747325 [No Abstract] [Full Text] [Related]
14. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria. Hokama S Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097 [No Abstract] [Full Text] [Related]
15. Therapeutic implications of nano-encapsulated rifabutin, azithromycin & ethambutol against experimental Grewal TK; Majeed S; Sharma S Indian J Med Res; 2018 Jun; 147(6):594-602. PubMed ID: 30168492 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, administered in various frequencies per week in Mycobacterium intracellulare-infected mice]. Tomioka H; Sato K; Saito H; Dekio S; Hidaka T Kekkaku; 1993 Nov; 68(11):683-6. PubMed ID: 8264123 [TBL] [Abstract][Full Text] [Related]
18. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results]. Tsukamura M; Yamori S Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003 [TBL] [Abstract][Full Text] [Related]
19. Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice. Yamamoto T; Amitani R; Suzuki K; Tanaka E; Murayama T; Kuze F Antimicrob Agents Chemother; 1996 Feb; 40(2):429-32. PubMed ID: 8834892 [TBL] [Abstract][Full Text] [Related]
20. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]